Wells Fargo
KBIO

Wells Fargo’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Wells Fargo’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-337
Closed -$5K – 6730
2014
Q4 		$5K Buy
+337
New +$4.81K ﹤0.01% 5897

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo's KBIO Position: Q1 2015 in Review

Wells Fargo sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 337 shares — an estimated $5K sold.

Wells Fargo first reported a position in KBIO in Q4 2014 and held it in 1 quarter. The position peaked at $5K in Q4 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • Wells Fargo reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • Wells Fargo sold 337 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $5K.
  • Wells Fargo first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2014 and held it in 1 quarter.
  • Wells Fargo's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $5K in Q4 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.